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Recent reports have shown that somatic cells, under
appropriate culture conditions, could be directly re-
programmed to cardiac, hepatic, or neuronal pheno-
type by lineage-specific transcription factors. In this
study,wedemonstrate that both embryonic andadult
somatic fibroblasts can be efficiently reprogrammed
to clonal multilineage hematopoietic progenitors by
the ectopic expression of the transcription factors
ERG, GATA2, LMO2, RUNX1c, and SCL. These re-
programmed cells were stably expanded on stromal
cells and possessed short-term reconstitution
ability in vivo. Loss of p53 function facilitated reprog-
ramming to blood, and p53/ reprogrammed cells
efficiently generated erythroid, megakaryocytic,
myeloid, and lymphoid lineages. Genome-wide ana-
lyses revealed that generation of hematopoietic
progenitors was preceded by the appearance of
hemogenic endothelial cells expressing endothelial
and hematopoietic genes. Altogether, our findings
suggest that direct reprogramming could represent
a valid alternative approach to the differentiation of
embryonic stem cells (ESCs) or induced pluripotent
stem cells (iPSCs) for disease modeling and autolo-
gous blood cell therapies.INTRODUCTION
Until recently, it was assumed that differentiation was mostly a
unidirectional and irreversible route that cells undertake during
lineage commitment. This dogma was rebutted by the ground-
breaking discovery of Yamanaka and colleagues that the
expression of four transcription factors (TFs) could reprogram
mouse and human cells into a pluripotent stage (Takahashi
and Yamanaka, 2006; Takahashi et al., 2007). Subsequent
studies have established that cellular-fate conversion is also ob-
tained by direct transdifferentiation between two distinct line-
ages. Transdifferentiation is generally achieved by overexpress-Cell Reing lineage-instructive TFs, as demonstrated by the effective
cell-fate switching of fibroblasts into neuronal, hepatocyte, and
cardiomyocyte lineages (Du et al., 2014; Huang et al., 2014;
Ieda et al., 2010; Nam et al., 2013; Sekiya and Suzuki, 2011; Vier-
buchen et al., 2010).
The hematopoietic system relies on the existence of a rare
population of hematopoietic stem cells (HSCs) that are able to
self-renew and reconstitute the entire system by generating all
hematopoietic lineages. In the clinic, transfusion of HSCs and
terminally differentiated blood cells (erythrocytes, platelets,
and granulocytes) is used to successfully treat blood genetic dis-
orders and malignancies. However, a major restriction to the
wider use of these treatments is the limited availability of cells
from donors with adequate match. An alternative strategy for
the generation of patient-specific hematopoietic cells would be
to differentiate induced pluripotent stem cells (iPSCs) to HSCs.
Unfortunately, so far, the development of robust methods to pro-
duce blood cells and, in particular, transplantable long-term
HSCs has met with limited success (Blum and Benvenisty,
2008; Sturgeon et al., 2013). Therefore, direct reprogramming
of patient-derived cells by transdifferentiation represents an
attractive alternative strategy for the generation of transplantable
blood cells.
Hematopoiesis is governed by the combined functions of
numerous TFs, complicating attempts to establish simple ap-
proaches toward transdifferentiation into this lineage. This
complexity is highlighted by knockout studies that identifiedmul-
tiple regulators of blood cell generation including SCL, RUNX1,
ERG, and GATA2 (Loughran et al., 2008; Okuda et al., 1996;
Robb et al., 1996; Tsai et al., 1994). Genome-wide chromatin
immunoprecipitation data indicated that these four factors, in
conjunction with LMO2, LYL1, and FLI1, create a regulatory
complex that mediates transcription of multiple genes in he-
matopoietic progenitor cells (Wilson et al., 2010). Each TF of
this heptad has been shown to act at multiple stages of hemato-
poietic specification, maturation, and differentiation (Loose et al.,
2007). For example, SCL is required during the formation of he-
mogenic endothelium precursors from hemangioblast and
mesoderm (Lancrin et al., 2010). RUNX1 is critical for the emer-
gence of hematopoietic progenitors and HSCs from hemogenic
endothelium (Chen et al., 2009; Lancrin et al., 2010). ERG is
required for the maintenance of fetal HSCs and also for theports 9, 1871–1884, December 11, 2014 ª2014 The Authors 1871
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self-renewal and survival of adult HSCs (Loughran et al., 2008;
Taoudi et al., 2011). Synergistic, antagonistic, and sequential re-
lationships among these TFs create complex regulatory land-
scapes that shape the hematopoietic identity (Pimanda and
Go¨ttgens, 2010).
Previous studies have revealed an inherent plasticity of he-
matopoietic cells, as they are amenable to transdifferentiation
and dedifferentiation. Recently, this approach has been remark-
ably employed for the generation of inducible HSCs (iHSCs) by
reprogramming blood cells or endothelium (Riddell et al., 2014;
Sandler et al., 2014). In both studies, cells capable of multiline-
age long-term engraftment were obtained by transient ectopic
expression of TFs selectively expressed in HSPCs. Importantly,
the successful generation of iHSCs required provision of a favor-
able niche for the maturation of the cells in the form of either
the in vivo bone marrow environment or a vascular support
mimicking the aorta-gonad-mesonephros (AGM) niche. How-
ever, reprogramming of differentiated blood cells might not be
suitable for the generation of healthy transplantable cells for pa-
tients with blood malignancies or acquired genetic diseases
(Pereira et al., 2014). In addition, it could prove very difficult to
obtain enough endothelial cells from an adult patient to perform
reprogramming. An approachmore appropriate for this purpose,
but alsomore challenging, would be to reprogrammore develop-
mentally distinct cell types, such as fibroblasts, into blood. In
this context, it has been shown that the TFs PU.1 and cEBPa
were capable of reprogramming fibroblasts into mature macro-
phage-like cells (Feng et al., 2008). However, reprogramming
of fibroblasts to more immature hematopoietic progenitors
has so far remained challenging. The first attempt, reported in
2010, involved the ectopic expression of the pluripotency factor
OCT4 in human fibroblasts (Szabo et al., 2010). Although
OCT4-induced hematopoietic progenitors exhibited myeloid
and erythroid potential, lymphoid potential and long-term in vivo
engraftment capacity were not achieved. Moreover, the use of
the pluripotent TF OCT4 also raises concerns about tumorige-
nicity, as partial reprogramming induced by OCT4 could mimic
a neoplastic state (Ohnishi et al., 2014). More recently, the
combinatorial expression of a limited set of hematopoietic TFs,
including GATA2, GFI1b, ETV6, and c-FOS in fibroblasts, was
shown to induce a hemogenic endothelial cell fate (Pereira
et al., 2013). However, the reprogrammed cells subsequently
displayed only minimal hematopoietic potential despite cocul-
ture with placental cells.Figure 1. Screen for Hematopoiesis-Inducing TFs
(A) Schematic representation of experimental strategy. Murine embryonic fibrobla
(MAFs) were prepared from adult ear skin. Cells expressing the surface markers
Sorted cells were transduced with a cocktail of all TFs. After 21 days of culture, ce
and cellular and nuclear morphology.
(B) Bright-field images of untransduced and all TFs transduced MEFs and MAFs
(C) Relative gene expression levels of indicated genes with respect to b-actin in
control E10.5 aorta-gonad-mesonephros (AGM) region cells. Data presented a
triplicate (n = 3; mean ± SD).
(D) Number of hematopoietic colonies generated by 50,000 all-TF-transduced
experiments performed in triplicates is shown (n = 2). Representative bright-field
(E) Cellular morphology of day 21 transduced MEFs/MAFs and ESC-derived hem
Gr, granulocyte; M, macrophage; P, progenitor; E, erythrocyte; Mk, megakaryo
(Student’s t test; ***p < 0.0005).
Cell ReIn this report, we establish that fibroblasts can be rapidly
and robustly reprogrammed to hematopoietic progenitors.
The ectopic expression of five hematopoietic TFs, functionally
selected from a range of 19 regulators, reproducibly induced
hematopoietic fate in adult and embryonic fibroblasts within
8 days. The reprogrammed progenitors exhibited multilineage
clonogenic capacity in vitro. Genome-wide transcriptional ana-
lyses of the reprogrammed cells revealed that the generation
of hematopoietic progenitors was preceded by a hemogenic
endothelial stage.
RESULTS
Reprogramming of Fibroblasts to Hematopoietic Fate
with a Pool of Hematopoietic TFs
The aim of the present study was to investigate whether the
ectopic expression of specific hematopoietic TFs could result
in a direct and rapid cell fate conversion to hematopoietic pre-
cursors. First, we carefully selected a set of 19 different hemato-
poietic TFs based on their expression and function during hema-
topoiesis (Table S1). The expression of most of the selected TFs
spans from the onset of blood development during ontogeny to
the adult blood system (Orkin and Zon, 2008). Lentiviruses ex-
pressing each individual factor were prepared and a cocktail of
all TFs was used to infect primary fibroblasts. As a source of
starting material, we used either embryonic day 14.5 (E14.5)
mouse embryonic fibroblasts (MEFs) or mouse adult ear skin fi-
broblasts (MAFs). Prior to infection, these cells were depleted of
any CD41-, CD31-, c-KIT-, and CD45-positive cells to eliminate
potential contamination by hematopoietic and endothelial cells
(Figure 1A). Posttransduction, the infected cells were switched
to a media supporting the growth of hematopoietic cells,
and the appearance of colonies containing round cells was
monitored daily. Starting from day 8, we observed in transduced
MEFs and MAFs cultures, but not in untransduced control cells,
the emergence of colonies of small round cells often associ-
ated with cobblestone-like areas (Figure 1B). These colonies
continued to expand during the following weeks of culture.
The transduced cells were next tested by immunostaining for
the acquisition of the hematopoietic cell-surface markers c-KIT
and CD41, which are expressed on emerging blood cells during
embryonic development (Mikkola et al., 2003; Mitjavila-Garcia
et al., 2002), and for the expression of hematopoietic genes.
Live staining at day 12 indicated that cells in emerging coloniessts (MEFs) were prepared from day 14.5 embryos, and murine adult fibroblasts
CD31, CD41, c-KIT, and CD45 were excluded from the starting populations.
lls were analyzed for hematopoietic cell-surface markers, clonogenic capacity,
at day 12.
untransduced (Un), all-TF-transduced MEFs, control bone marrow (BM), and
re representative of one out of three independent experiments performed in
day 21 harvested MEFs/MAFs (left). Mean ± SEM from two independent
images of the different types of colonies observed (right).
atopoietic cells. Arrowheads depict indicated morphologies.
cyte, Scale bars represent 50 mm. Asterisks indicate significant differences
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Figure 2. Five TFs Induce Reprogramming to Blood
(A) Bright-field images of five TFs transduced MEFs/MAFs at day 12 (left). Number of round cell colonies observed per 15,000 transduced MEFs/MAFs (right,
n = 5, mean ± SEM).
(B) FACS analysis of untransduced and five-TF-transduced MEFs and MAFs at day 21.
(legend continued on next page)
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were positive for CD41 expression (Figure S1A). Flow cytometry
(fluorescence-activated cell sorting [FACS]) analyses at day 21
confirmed the acquisition of CD41 and low levels of c-KIT
expression by the transduced MEFs and MAFs (Figure S1B).
Gene expression analyses on 3-weeks-posttransduced cells
clearly indicated the downregulation of the fibroblasts markers
(Acta2 and Fbn1) (Figure 1C). In contrast, the expression of
genes associated with erythroid (embryonic b-H1 and adult
b-major hemoglobin), megakaryocytic (Pf4), and myeloid (Itgam
and Mpo) lineages were markedly upregulated in these cultures
(Figure 1C). The expression of both b-H1 and b-major hemoglo-
bin genes suggests the presence of both primitive and definitive
erythroid cells in these cultures. Having demonstrated the
induction of a hematopoietic gene signature, we next sought to
determine whether the reprogrammed cells possessed func-
tional hematopoietic clonogenic potential. Day 21 reprog-
rammed MEFs and MAFs, but not untransduced fibroblasts,
generated hematopoietic colonies containing macrophage,
erythroid, and granulocytic cells upon replating in clonogenic as-
says (Figure 1D). May-Gru¨nwald Giemsa staining confirmed the
presence of cells with erythroid, megakaryocytic, and myeloid
morphologies in these colonies (Figure 1E). Collectively, these
experiments established that both embryonic and adult fibro-
blasts could be reprogrammed to hematopoietic cells upon the
ectopic expression of 19 hematopoietic TFs.
ERG, GATA2, LMO2, RUNX1c, and SCL Reprogram
Fibroblasts to Blood
Our next aim was to define the minimal combination of TFs
required for reprogramming to blood cells. By eliminating each
TF individually from the pool, taking into account the redundancy
among TFs, and reiteration, we established that a minimal set of
five TFs (ERG, GATA2, LMO2, RUNX1c, and SCL) was able to
robustly and reproducibly induce the generation of colonies of
round cells in both adult and embryonic fibroblasts (Figure 2A,
left; Movie S1). The efficiency of reprogramming was consis-
tently higher in MEFs than in MAFs (Figure 2A, right). Several
other combinations of TFs could also induce the generation
of hematopoietic colonies from MEFs, albeit with lower effi-
ciencies. The combination of ERG, FLI1, GATA2, PU.1, and
SCL or the triad of FLI1, GATA2, and SCL, which controls the
specification of mammalian hematopoietic progenitors (Pi-
manda et al., 2007), induced the generation of hematopoietic
colonies in MEFs (Figure S2A). However, as the combination of
the five TFs efficiently and reproducibly reprogrammed both
MEFs and MAFs, we selected this set for further experiments.
FACS analyses of day 21 MEF and MAF transduced cultures
confirmed the acquisition of the hematopoietic markers c-KIT,
CD41, CD45, CD11b, and TER119 (Figure 2B). Clonogenic
assays and cytospin analysis of day 21 reprogrammed cells
confirmed that five-TF-transduced MEFs and MAFs exhibited
erythroid and myeloid potential (Figures 2C and 2D). Finally,(C) Number of hematopoietic colonies generated by 50,000 five-TF-transduced d
field images of the different types of colonies observed (right).
(D) Cellular morphology analyses of day 21 transduced MEFs/MAFs and control b
granulocyte; M, macrophage; P, progenitor; E, erythrocyte; Mk, megakaryocyte.
(E) Phagocytic capacity of CD45/CD11b double-positive cells. Asterisks indicate
Cell Resorted CD45/CD11b double-positive cells were able to uptake
red fluorescent latex beads, demonstrating their phagocytic
capacity and functionality (Figure 2E).
We next set out to determine the specific requirement for each
TF and therefore performed ‘‘Nminus 1’’ experiments. In MAFs,
SCL, LMO2, and RUNX1c were more important than ERG and
GATA2 for the generation of hematopoietic colonies (FigureS2B).
In MEFs, SCL and LMO2 alone were sufficient, albeit at a lower
efficiency, to generate hematopoietic colonies containing
CD41-, CD45-, and c-KIT-positive cells (Figure S2C); in contrast,
no colonies were obtained with these two TFs in MAFs (Fig-
ure S2C). To investigate if the hematopoietic phenotype of the re-
programmedcellswasdependent on the sustainedexpressionof
the exogenous TFs, we performed quantitative RT-PCR (qRT-
PCR) on day 4 and day 21 transducedMEFswith primers specific
for exogenous transduced factors. These experiments demon-
strated that the vector-driven transcription of all five TFs was
silenced by day 21 (Figure S2D). In contrast, vector integration
of all five viruses was enriched upon the emergence and expan-
sion of blood cells in these cultures (Figure S2E). These results
established the contribution of all five exogenous factors in the
induction of the hematopoietic program. In addition, qRT-PCR
specific for the endogenous genes indicated that expression of
all five endogenous TFswas induced during reprogramming (Fig-
ure S2F). Finally, to determine the growth factors and cytokines
essential to reprogramfibroblasts,weperformed ‘‘Nminus1’’ ex-
periments with MEFs. We observed that interleukin-3 (IL-3) was
absolutely critical for reprogramming (Figure S2G), a finding
consistent with its established role in the maintenance of
hematopoietic progenitor cells. Collectively, our results indicate
that the combination of ERG, GATA2, LMO2, RUNX1c, and
SCL efficiently induces reprogramming of both embryonic and
adult fibroblasts to blood.
Five-TF-Induced Reprogramming Generates
Multipotent Progenitors
Both morphological analysis and cell-surface staining data sug-
gested that a large fraction of day 21 reprogrammed hematopoi-
etic cells were already mature and differentiated at this stage
(Figure 2D). To investigate whether fibroblasts were reprog-
rammed through a transient hematopoietic progenitor stage, or
transdifferentiated more directly to mature blood cells, we inves-
tigated the emergence of cells positive for hematopoietic precur-
sormarkersbyFACS.Weobserved fromday10onwarda sudden
rise in the frequencyof c-KIT/CD41double-positive cells followed
by a similar rise in the emergence of CD45+ cells fromday 12 (Fig-
ure 3A). Time-course replating of transduced MEF cultures in
semisolid colony assays indicated a transient peak of clonogenic
potential around day 12–15 (Figure 3B), which correlated with
higher frequencies of c-KIT+ cells. A similar gradual increase in
the number of c-KIT+ cells and peak of clonogenic potential was
observed in transduced MAF cultures (Figures S3A and S3B).ay 21 harvested MEFs/MAFs (left, n = 4, mean ± SEM). Representative bright-
one marrow (BM) derived cells. Arrowheads depict indicated morphology. Gr,
Scale bars represent 50 mm.
significant differences (Student’s t test; **p < 0.01).
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Figure 3. Multilineage Potential of Five-TF-Reprogrammed Cells
(A) Acquisition of hematopoietic cell surface markers during the course of reprogramming. Average percentages of cells expressing CD41, c-KIT, and CD45 are
represented at indicated intervals after five-TF transduction of MEFs (n = 2, performed in duplicate; mean ± SD).
(B) Number of hematopoietic colonies generated by 50,000 reprogrammed MEFs from day 7 to day 21 (n = 2, performed in duplicate; mean ± SEM).
(C and D) Multilineage potential of five TFs reprogrammed day 12 sorted c-KIT+ cells. (C) Sorted c-KIT+ cells were cultured under erythroid and myeloid culture
conditions for 1 week and FACS analyzed for cell-surface markers. (D) Morphology of colonies and cells generated by sorted c-KIT+ cells.
(E) FACS and cellular morphology of cells derived from day 12 sorted single c-KIT+ cell expanded on OP9 for 2 weeks (n = 3).
(F) Percentage reconstitution in peripheral blood determined by detection of donor-derived GFP+ cells after 2 weeks of transplantation in two individual mice per
group (1 and 2) either with GFP+ or c-KIT+ reprogrammed cells.
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Confirming the relationship between c-KIT acquisition and clono-
genic potential, c-KIT+ cells displayed a higher clonogenic poten-
tial than c-KIT cells (data not shown). When c-KIT+ sorted cells
were cultured in conditions that specifically support the growth
of erythroid and myeloid cells, CD71/TER119 and CD11b/GR1
double-positive cells were respectively detected (Figure 3C).
When evaluated in clonogenic replating assays, c-KIT+ cells
generated colonies containing erythroid, megakaryocytic, and
myeloid cells (Figure 3D). Relatively similar genomic integration
levels of the five vectors were observed between erythroid
TER119 and myeloid CD11b-positive cells (Figure S3C). This
observation suggests that both lineages have similar TF require-
ments for their generation and/or that they are generated through
a common progenitor. Collectively, these results indicate that
hematopoietic progenitors withmyeloid, erythroid, andmegakar-
yocytic potential are generated early during reprogramming.
To investigate the presence of multipotential progenitors, we
evaluated the frequency of clonogenic precursors in the c-KIT+
fraction, containing all hematopoietic progenitor cells, including
the most immature precursors. Limiting dilution analyses indi-
cated that 1 in 20 c-KIT+ cells generated colonies when cultured
on OP-9 stromal cells (data not shown). To investigate if c-KIT+
cells have multilineage clonal ability, single day 12 fibroblast-
derived c-KIT+ cells were sorted onto OP-9 stromal cells and
amplified for 2 weeks (Figure 3E). FACS and May-Gru¨nwald
Giemsa staining indicated the presence of erythroid, myeloid,
and megakaryocytic cells in cultures initiated with a single
c-KIT+ cell (Figure 3E). These results suggest that fibroblasts
are reprogrammed to the blood program, at least in part, through
multipotential hematopoietic progenitor cells.
To further determine if hematopoietic stem cells might be
generated during reprogramming, we performed FACS analyses
for the SLAM markers on day 12 reprogrammed cells that were
amplified on OP9-DL1. LINc-KIT+SCA1+ (LSK) cells were de-
tected in these cultures, and some of the LSK cells were
CD48CD150+, indicating the presence of phenotypic HSCs
(Figure S3D). Additionally, we also observed phenotypic HSCs
identified by the combination EPCR+CD48CD45+CD150+ (Fig-
ure S4A). We next investigated if these reprogrammed cells have
the capacity to engraft mice in vivo. For this, we established
E14.5 MEFs from a transgenic mouse carrying the GFP reporter
cDNA under the control of the pan-hematopoietic AI467606
gene promoter (Ferreras et al., 2011). We amplified day 12 re-
programmed cells on OP9-DL1 stromal cells for 2 weeks. At
this stage, GFP+ cells, characterizing both progenitors and
differentiated cells, or c-KIT+ cells, including the most immature
progenitors, were sorted and injected into two irradiated immu-
nocompromised mice per each group. After 2 weeks, we moni-
tored the presence of GFP+ cells in the peripheral blood and
detected short-term engraftment of both injected populations
(Figures 3F and S4B). Engrafted cells were mostly TER119+
erythroid cells (Figure S4B). However, 8 weeks postinjection,
we could not detect engraftment greater than 1% in peripheral
blood (data not shown). Collectively, these results suggest that
the five-TF-mediated reprogrammed cells have short-term
engraftment capacity and that further optimization of the culture
conditions or TF composition will be necessary to obtain long-
term engraftment capacity.Cell ReLoss of p53 Increases the Efficiency of Reprogramming
to Blood
The loss of p53 or p16/p19 function has been shown to dramat-
ically improve the efficiency of reprogramming to the pluripotent
state (Hong et al., 2009; Li et al., 2009).We therefore investigated
whether similarly deletion of these genes improved reprogram-
ming of fibroblasts to blood. Following transduction with the
five TFs, we observed significantly higher numbers of hemato-
poietic colonies generated by p53 and p16/p19-null MEFs than
by wild-type MEFs (Figure 4A). These colonies emerged as early
as 5 days after transduction, and scoring was performed on day
6, as their excessive proliferation precluded individual counting
at later time points. Reprogramming of p53/ MEFs resulted
in the emergence of hematopoietic progenitors with multilineage
potential (Figures 4B and 4C). Also, loss of p53 or p16/p19 func-
tion significantly increased the frequency of TER119+ erythroid
cells generated by reprogrammed cells (Figure 4D). Cells with
mature megakaryocytic morphologies that stained positive for
acetylcholinesterase activity were also more readily observed
with p53/ reprogrammed MEFs (Figure 4E). To evaluate
the lymphoid potential of p53/ reprogrammed cells, sorted
c-KIT+ cells were cultured and passaged on OP-9 or OP9-DL1
stromal cells in culture conditions supporting B or T cell growth,
respectively. Cells positive for the B cell markers B220/CD19
emerged and proliferated during the culture of reprogrammed
p53/MEFs (Figure 4Fi). A fraction of B220/CD19 double-pos-
itive reprogrammed p53/ cells were also positive for immuno-
globulin M expression (Figure 4Fi). The B cell identity of sorted
B220/CD19-positive cells was further confirmed by detection
of V(D)J chain rearrangements by PCR and sequencing (Fig-
ure 4Fii). Similarly, some reprogrammed p53/ MEFs cells
cultured on OP9-DL1 stromal cells acquired the expression of
the early T cell marker CD25 and displayed T cell receptor
rearrangements, confirming early T lymphoid commitment
(Figures 4Gi and 4Gii). Collectively, these results demonstrate
that p53/MEFs aremore efficiently reprogrammed to hemato-
poietic progenitors with erythroid, myeloid, megakaryocyte, and
B and T lymphoid lineage potential than wild-type MEFs, indi-
cating that P53 expression is a barrier for reprogramming to
blood.
Reprogramming to Blood Occurs via an Intermediate
Endothelial Stage
We next investigated the molecular events and cellular pro-
cesses leading to the reprogramming of fibroblasts to blood
progenitors. The rapid emergence of hematopoietic colonies
suggested that the reprogramming did not involve a pluripotent
stem cell stage with subsequent differentiation into blood
cells. Accordingly, the expression of pluripotent markers (Oct4,
Sox2, andNanog) was not detected during the course of reprog-
ramming (Figure 5A). The detection of embryonic hemoglobin
b-H1 expression in reprogrammed cells (Figure 1C) suggested
that the reprogramming process might recapitulate to some
extent embryonic hematopoiesis. During embryonic hematopoi-
esis, mesodermal hemangioblast precursors generate primitive
as well as definitive blood cells through an intermediate hemo-
genic endothelium stage. We evaluated by PCR whether the re-
programming of fibroblasts to blood process was associatedports 9, 1871–1884, December 11, 2014 ª2014 The Authors 1877
Figure 4. Reprogramming p53-Null MEFs
(A) Number of round cell colonies observed at day 6 per 15,000 transduced WT, p53/, and p16/p19/ MEFs (n = 4; mean ± SEM).
(B) Number and types of hematopoietic colonies generated by 50,000 five-TF-reprogrammed p53/ MEFs harvested from day 6 to 15. Data presented are
mean ± SEM of triplicates in a representative experiment (n = 2).
(legend continued on next page)
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with any of these distinct embryonic steps. Although we did not
detect any expression of the Brachyury mesodermal marker
(data not shown), we clearly observed a peak of endothelial
gene expression (Cdh5, Tie2, and Icam1; Pecam1 and Vwf) early
in reprogramming (Figures 5B and 5C). In contrast, hematopoiet-
ic genes (Itga2b, Mpo, and Pu.1) showed a delayed but steady
increase in expression from day 12 to day 21 (Figure 5D). Live
staining for vascular endothelial cadherin (CDH5) performed on
day 5 cultures confirmed the early emergence of clusters of
CDH5+ endothelial cells (Figure 5E). To determine if these endo-
thelial cells corresponded to hemogenic endothelium that gives
rise to differentiated blood cells, we sorted CDH5+ and CDH5
cells from c-KIT-depleted day 6 transduced MEFs to eliminate
any potential hematopoietic precursors. The cells were then
cultured in conditions that support the transition to hematopoiet-
ic progenitors before seeding them in clonogenic assays. As
shown in Figure 5F, CDH5+, but not CDH5, cells generated he-
matopoietic colonies, demonstrating their hemogenic potential.
In addition, these c-KIT/CDH5+ endothelial cells acquired the
hematopoietic markers CD41, CD45, and c-KIT upon culture
on OP9 (Figure S5A). We concluded from these results that re-
programming of fibroblasts to blood cells proceeds through an
intermediate hemogenic endothelial cellular stage.Transcriptome Analyses on Reprogrammed Cells
To define the global changes in gene expression driving reprog-
ramming of fibroblasts to hematopoietic lineages, we performed
exon array analyses on biological replicates of untreated MEFs
(Un), day 8 sorted CDH5+ cells, and day 12 sorted c-KIT+ cells.
We identified 868 significantly (5% false discovery rate [FDR])
differentially expressed genes (DEGs). Principal component
analyses based on these DEGs confirmed the correlation be-
tween replicates and the differences between cells at the three
stages of reprogramming (Figure S6A). We then performed hier-
archical clustering on DEGs and observed three main clusters
(Figure 6A). The first cluster mostly contained genes that were
gradually downregulated from untransduced MEFs to CDH5+
and then to c-KIT+ populations and were associated with adhe-
sion and muscular development (Figure 6A; Table S2). This clus-
ter included fibroblast-specific genes (Acta2, Actg2, Col2A,
Col4a1, Col5a1, and Fgf3) that were silenced during reprogram-
ming. The second cluster encompassed genes that were upre-
gulated in CDH5+ cells but then downregulated in c-KIT+ cells.
These genes were mainly of endothelial nature and associated
with blood vessel development and cell-cell adhesion (Figure 6A;
Table S2). The third cluster included genes that were moderately
expressed in CDH5+ cells, highly expressed in c-KIT+ popula-
tions, and associated with ontology terms such as development(C) Morphology of colonies and cells obtained from five-TF-transduced day 12 s
(D) Average percentage of TER119 and CD11b/GR1 double-positive cells generat
MEFs (n = 3; mean ± SEM).
(E) Acetylcholinesterase staining of megakaryocytes derived from bone marrow
(Fi) FACS analysis of c-KIT+ sorted reprogrammed p53/ MEFs after expansion
(Fii) BCR rearrangements detection in B220+/CD19+ sorted reprogrammed p53
(Gi) FACS analysis of c-KIT+ sorted reprogrammed p53/ MEFs after expansion
(Gii) TCR rearrangement detection in sorted CD25+ reprogrammed p53/ MEFs
Asterisk(s) represents statistical significance (Student’s t test; *p < 0.05, **p < 0.
Cell Reof the hematopoietic program, leukocyte migration, chemotaxis,
and response to infection/wounding ontology terms (Figure 6A;
Table S2). Pathway analyses with DAVID confirmed that hemato-
poietic pathways were already activated in the CDH5+ fraction, a
finding consistent with a hemogenic endothelium identity (Table
S2). To further confirm this transient upregulation of the endo-
thelial program, we performed gene set enrichment analyses
(GSEA) with endothelial-specific genes. As expected, genes up-
regulated between MEFs and CDH5+ cells, and downregulated
between CDH5+ and c-KIT+ cells, were positively correlated
with an endothelial gene signature (Figure 6B). These analyses
also indicated an enrichment for genes specifically upregulated
in CDH5+ cells for early hematopoietic progenitors signature,
whereas c-KIT+-specific genes were more closely associated
with late or differentiated hematopoietic progenitor cells (Figures
6C and S6B). Finally, we investigated to which extent our reprog-
rammed cells were similar to HSCs by comparing our transcrip-
tome signature with previously published data sets from different
HSC populations isolated from diverse hematopoietic tissues
(McKinney-Freeman et al., 2012). We observed that CDH5+ cells
clustered with AGM, placental, and yolk sac HSCs that have
been classified as specifying HSCs. Interestingly, c-KIT+ cells
clustered more closely with definitive HSCs from fetal liver,
bone marrow, and embryonic stem cell (ESC)-derived HSCs
(Figure 6D). Collectively, our transcriptome analyses further sup-
port the concept that reprogramming to hematopoietic progen-
itors proceeds through a hemogenic endothelium intermediate.
This CDH5+ cell population, while displaying clear evidence of
its endothelial nature, also expressed hematopoietic genes
and displayed similarity with emerging HSCs and early progeni-
tors, whereas the later c-KIT+ population wasmore closely asso-
ciated with hematopoietic progenitors.DISCUSSION
In this study, we establish that fibroblasts can be robustly re-
programmed to hematopoietic cell fate by concomitant ectopic
expression of the hematopoietic TFs ERG, GATA2, LMO2,
RUNX1c, and SCL. These five TFs have been shown to interact
and act at diverse stages of the hematopoietic program; i.e.,
from the onset of its development to the more established
adult hematopoietic hierarchy (Wilson et al., 2010). In partic-
ular, SCL, GATA2, and FLI1, a distinct but related-to-ERG
ETS factor, form an interconnected regulatory triad that is acti-
vated during specification of HSCs (Pimanda et al., 2007).
Once established, this circuit is self-maintained, providing the
newly specified progenitors with a memory of their stemness
in a similar fashion as OCT4, SOX2, and NANOG in pluripotentorted c-KIT+ p53/ MEFs.
ed by day 12 sorted c-KIT+ cells fromWT, p53/, and p16/p19/ transduced
or generated by day 12 sorted c-KIT+ reprogrammed p53/ MEFs.
on OP9 in lymphoid medium.
/ MEFs, control untransduced MEFs (Un) and spleen cells.
on OP9-DL1 in lymphoid medium.
, control untransduced MEFs (Un) and thymus cells.
01).
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Figure 5. Fibroblasts Are Reprogrammed to Blood via an Intermediate Hemogenic Endothelial Stage
(A–D) Relative gene expression levels of pluripotent (A), endothelial (B), endothelial/ hematopoietic (C), and hematopoietic (D) markers with respect to b-actin at
indicated days after five-TF transduction and in control bone marrow (BM) and aorta-gonad-mesonephros (AGM) region cells. Data presented are mean ± SD
from one representative experiment (n = 3).
(E) Immunostaining of day 5 five-TF-transduced MEFs for CDH5 (red) and DAPI (blue).
(F) Schematic strategy to determine hemogenic potential of CDH5cKIT and CDH5+cKIT five-TF-transduced cells (top). Number, type, and morphology of
hematopoietic colonies generated by sorted cells reaggregated with irradiated OP9 stromal cells.
Data presented are mean ± SEM of triplicates of a representative experiment (n = 2). Scale bars represent 50 mm.ESCs (Boyer et al., 2005). Furthermore, ERG, when expressed
along with HOXA9 and RORA, has also been shown to confer
multilineage potential to myeloid-restricted precursors (Doula-
tov et al., 2013). The transcription factor SCL and its binding
partners are implicated in the induction of the hematopoietic
program in mesoderm and the generation of hemogenic endo-1880 Cell Reports 9, 1871–1884, December 11, 2014 ª2014 The Autthelium (Gering et al., 2003; Lancrin et al., 2009). Finally,
RUNX1 physically interacts with SCL, ERG, and GATA2 and
is critical for the transition from hemogenic endothelium
to hematopoietic stem and progenitor cells (HSPCs) (Chen
et al., 2009; Lancrin et al., 2010; Wilson et al., 2010). Further-
more, enforced expression of the isoform RUNX1a enhanceshors
Figure 6. Global Transcriptome Analyses of
Reprogrammed Cells
Day 8 CDH5+ (CDH5-positive) and day 12 c-KIT+
(c-KIT-positive) flow-sorted cells were compared
to untreated (Un) MEFs in duplicate by mouse
Affymetrix exon arrays.
(A) Hierarchical clustering of differentially ex-
pressed genes (DEGs) among untreated MEFs,
day 8 sorted CDH5+, and day 12 sorted c-KIT+
cells. Genes specific to specified cell types are
shown on the right.
(B) Gene set enrichment analysis (GSEA) for
endothelial gene signature in untreated, CDH5+,
and c-KIT+ transcriptomes.
(C) Normalized enrichment score (NES) values
obtained after performing GSEA for indicated gene
sets comparing CDH5+ and c-KIT+ transcriptome
data sets.
(D) Unsupervised hierarchical clustering of DEGs in
our transcriptome data sets along with expression
in HSCs from different hematopoietic organs
(McKinney-Freeman et al., 2012).hematopoietic lineage commitment from human ESCs and
iPSCs (Ran et al., 2013). The close functional association
among these five TFs during normal HSPCs generation could
explain why we functionally identified them as the best
combination of TFs to robustly induce a complex hematopoiet-
ic program in differentiated fibroblasts. Interestingly we also
demonstrated that SCL and LMO2 are sufficient to induce he-
matopoietic fate in embryonic but not adult fibroblasts. This
finding raises the interesting prospect that a limited set of
small-molecule modulators could reinforce reprogramming or
even circumvent the need for viral transduction.Cell Reports 9, 1871–1884, DeWe observed that the generation of
blood precursors by the ectopic expres-
sion of our set of five TFs is a very fast pro-
cess. The first morphological signs of cell-
fate switching were observed by day 5
followed by the emergence and prolifera-
tion of c-KIT+ progenitors by 8 days. These
cells exhibited a wide range of differen-
tiation potential with robust generation of
granulocytes and functionalmacrophages
and, to a lower extent, erythrocytes
and megakaryocytes. Furthermore, using
fibroblasts with a p53/ background
broadened the range and increased the
frequency of the generated lineages.
In addition to larger pool of erythrocytes
and megakaryocytes, we were able to
generateBandTcells atdifferent develop-
mental stages. The results obtained with
p53/ MEFs provide a proof of principle
that our combination of five TFs is suitable
for reprogramming to all major blood line-
ages. The addition of small-molecule
modulators that transiently increase
epigenetic plasticity or briefly inhibit p53or p16 might further extend the range and frequency of lineages
generated from wild-type fibroblasts. In contrast, a permanent
inactivation of p53 might not be desirable given the requirement
for p53 to limit aberrant self-renewal (Zhao et al., 2010).
Establishing methods for transdifferentiation of nonhemato-
poietic cells to blood lineage remains challenging due to signif-
icant epigenetic barriers to overcome and the need to induce
and maintain complex regulatory networks in these cells. So
far, there are only two reports describing transdifferentiation
of fibroblasts to blood progenitors. In the first study, hematopoi-
etic progenitors with multilineage potential were generatedcember 11, 2014 ª2014 The Authors 1881
by overexpression of a single pluripotency factor, OCT4, in a
hematopoietic-supportive culture environment (Szabo et al.,
2010). The use of a pluripotent TF, however, raises some
concerns about tumorigenicity. In the second report, Pereira
et al. demonstrated that ectopic expression of c-FOS, ETV6,
GATA2, and GFI1b reprogrammed fibroblasts to hemogenic
endothelial cells, which upon further coculture with placental
cells generated myeloid cells, albeit with a low efficiency
(around 10 colonies for 100,000 starting MEFs) (Pereira et al.,
2013). Although reprogramming by c-FOS, ETV6, GATA2, and
GFI1b, as well as our combination of five TFs, seems to transit
through a similar hemogenic endothelium intermediate stage,
the efficiency and kinetics are quite different. While these au-
thors identified a hemogenic endothelium population emerging
by day 35 of reprogramming, our results indicate the emergence
of an endothelial population as early as day 5. We detected
c-KIT+ functional hematopoietic progenitors with multilineage
potential as early as 8 days after transduction, whereas Pereira
et al. obtained only limited myeloid potential after more than
6 weeks of culture. Collectively, these results indicate that
our combination of TFs induce the rapid generation of a multi-
potent blood progenitors with better efficiency than previously
reported.
Several lines of evidence suggest that the reprogramming of
fibroblasts to blood cells recapitulates the embryonic process
of blood development. CD41, the first hematopoietic marker
we detected at the surface of transitioning reprogrammed cells,
is widely expressed on the earliest blood progenitors generated
during ontogeny (Figure S1A) (Ferkowicz et al., 2003; Mikkola
et al., 2003; Mitjavila-Garcia et al., 2002; Robin et al., 2011).
The detection of primitive erythrocytes expressing the embry-
onic bH1-hemoglobin also suggests that these TFs are inducing
early developmental steps. Moreover, the presence of a tran-
sient hemogenic endothelium population resembles the endo-
thelial-to-hematopoietic transition that takes place during blood
development in the yolk sac or dorsal aorta (Boisset et al., 2010;
Jaffredo et al., 1998; Lancrin et al., 2009; Zovein et al., 2008).
Finally, the detection of phenotypic HSCs, as well as the gene
expression profile clustering of the CDH5+ cell population with
specifying HSC cell populations, further supports the hypothe-
sis that the reprogramming mimics early hematopoietic de-
velopment (Figures 6D, S3D, and S4A). The fact that we are
recapitulating the normal embryonic program of blood develop-
ment suggests that it may be only due to the limitations of the
in vitro cultures that we cannot functionally identify an emerging
HSC population. The reports by the Rossi and Rafii’s labora-
tories emphasize the requirement for a supportive niche to
obtain engraftable populations upon reprogramming of blood
or endothelial cells (Riddell et al., 2014; Sandler et al., 2014).
Providing a similar in vivo bone marrow or in vitro vascular sup-
port might greatly improve the repopulation potential of cells
generated from fibroblasts and therefore will be a major direc-
tion for further research.
In conclusion, we provide a report of efficient and rapid re-
programming of fibroblasts to blood progenitors with a limited
set of hematopoietic TFs. Fibroblasts represent an accessible
and safe starting cell population for reprogramming. Despite
many remaining questions, the approach reported here holds a1882 Cell Reports 9, 1871–1884, December 11, 2014 ª2014 The Authuge promise and should be further optimized and developed
for its safe use in clinical settings.
EXPERIMENTAL PROCEDURES
MEF and MAF Preparation
E14.5 MEFs were isolated as described previously (Sroczynska et al.,
2009). MAFs were isolated from the ears of 2- to 6-month-old mice by
collagenase digestion. Passage 0 fibroblasts were cultured until confluent
and frozen. Before infection, MEFs and MAFs were depleted of cells pos-
itive for the hematopoietic/endothelial markers CD41, CD31, c-KIT, and
CD45.
Lentivirus Transduction, Colony-Forming Unit Assay, and
Reaggregation
MEFs/MAFs (15,000) were seeded on a gelatin-coated 12-well plate, and after
24 hr viral transductions were carried out in the presence of 10 mg/ml diethy-
laminoethyl dextran. After 4 hr of transduction, the cultures were placed in he-
matopoietic media (13 Iscove’s modified Dulbecco’s medium supplemented
with plasma-derived serum [PDS; Antech], 10% protein-free hybridoma
medium [PFM; GIBCO], 0.5 mM ascorbic acid, 4.5 3 104 M MTG, 2 mM
L-glutamine, 80 mg/ml transferrin, 1% c-KIT ligand, 1% IL-3, 1% granulo-
cyte-macrophage colony-stimulating factor, 1% thrombopoietin conditioned
media, 4 U/ml erythropoietin [Ortho-Biotech], 10 ng/ml macrophage colony-
stimulating factor, 10 ng/ml IL-6, 5 ng/ml IL-11 [all from R&D Systems], and
50 mg/ml penicillin-streptomycin). Colony-forming unit (cfu) assays were per-
formed as described previously (Sroczynska et al., 2009). To evaluate the pres-
ence of hemogenic endothelium, CDH5+ and CDH5 cells were sorted from
day 6 cultures that were depleted for c-KIT+ cells to avoid hematopoietic
contamination. A total of 20,000 sorted cells were mixed with 100,000 irradi-
ated OP9 cells, cultured overnight in hanging-drop cultures, and then on Du-
rapore filter (Millipore) for another 4 days. Single-cell suspensions obtained
following dissociation with collagenase/dispase solution were assayed in cfu
assays.
Transplantation Assay
E14.5 MEFs for transplantation experiments were obtained from a reporter
mouse line with GFP expression under the control of AI467606 promoter (Fer-
reras et al., 2011). Day 12 transduced cells were harvested and further
expanded for 2 weeks on OP-DL1 stroma cells in hematopoietic medium.
GFP- or c-KIT-positive cells were sorted and intravenously injected in 6- to
8-week-old lethally irradiated NSG mice (n = 2). The level of engraftment
was determined by GFP expression in peripheral blood. All animal work was
performed under regulations set out by the Home Office Legislation under
the 1986 United Kingdom Animal Scientific Procedures Act.
Affymetrix Analyses and Integration of Data Sets
Global gene expression analyses were done using the Mouse Exon 1.0 ST
arrays. The R/Bioconductor package LIMMA was used to identify genes that
were differentially expressed among the three conditions. Differentially ex-
pressed genes were obtained with significant p value and at 5% FDR. The dis-
tance weighted discrimination (Benito et al., 2004) method for cross-platform
normalization was done for our transcriptome data sets along with McKinney
data sets (McKinney-Freeman et al., 2012). Hierarchical clustering was per-
formed using the complete linkage.
ACCESSION NUMBERS
Affymetrix data were deposited in the Gene Expression Omnibus under the
accession number GSE59428.
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